MONECO Advisors LLC Has $589,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

MONECO Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,129 shares of the medical equipment provider’s stock after acquiring an additional 85 shares during the period. MONECO Advisors LLC’s holdings in Intuitive Surgical were worth $589,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. Sierra Ocean LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $40,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,240 shares of company stock worth $3,529,040 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.1 %

NASDAQ ISRG opened at $591.01 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $210.51 billion, a PE ratio of 92.20, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The firm’s 50 day moving average is $566.43 and its 200-day moving average is $526.49.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.